Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer

Cited by (1,005)

Items 1,001–1,005 of 1,005

1. Low dosage combination treatment with metformin and simvastatin inhibits obesity-promoted pancreatic cancer development in male KrasG12D mice
   Teper, Yaroslav, Ye, Linda, Waldron, Richard T., Lugea, Aurelia, Sun, Xiaoying, Sinnett-Smith, James, Hines, Oscar J., Pandol, Stephen J., Rozengurt, Enrique, Eibl, Guido · 2023 · Scientific Reports
2. GLDC promotes colorectal cancer metastasis through epithelial–mesenchymal transition mediated by Hippo signaling pathway
   Yu, Hao, Hu, Xueqing, Zhang, Yingru, Wang, Jiajia, Ni, Zhongya, Wang, Yan, Zhu, Huirong · 2023 · Medical Oncology
3. HBO1 functions as an epigenetic barrier to hepatocyte plasticity and reprogramming during liver injury
   Yuan, Wei-Chien, Earl, Andrew S., Ma, Sai, Alcedo, Karel, Russell, Jacquelyn O., Duarte, Fabiana M., Chu, Yen-Ting, Chang, Pei-Chi, Chen, Hsin-Yi, Chi, Hsin-Hui et al. · 2025 · Cell Stem Cell
4. The EZH2 selective inhibitor ZLD1039 attenuates UUO-induced renal fibrosis by suppressing YAP activation
   Xia, Qingling, Xu, Fujiang, Zhang, Lidan, Ding, Wenfei, Liu, Jiang, Liu, Jing, Chen, Minhao, Ou, Santao, Xu, Yong, Wen, Li · 2025 · Molecular Biomedicine
5. Expression patterns of Yes-associated protein 1 in the developing mouse liver
   Wei, Wei, Lotto, Jeremy, Hoodless, Pamela A. · 2018 · Gene Expression Patterns